Anakinra Drug Retention Rate and Predictive Factors of Long-Term Response in Systemic Juvenile Idiopathic Arthritis and Adult Onset Still Disease
Jurgen Sota(Azienda Ospedaliera Universitaria Senese), Luca Cantarini(University of Siena), Salvatore De Vita(University of Udine), Salvatore Grosso(University of Siena), Marta Mosca(University of Pisa), Giuseppe Lopalco(University of Bari Aldo Moro), Serena Colafrancesco(Sapienza University of Rome), Antonio Vitale(University of Siena), Ombretta Viapiana(University of Verona), Rosaria Talarico(University of Pisa), Piero Ruscitti(University of L'Aquila), Paolo Sfriso(University of Padua), Roberto Giacomelli(Policlinico Umberto I), Francesco La Torre(Ospedale Vito Fazzi), Manuela Pardeo(Istituti di Ricovero e Cura a Carattere Scientifico), Donato Rigante(Agostino Gemelli University Polyclinic), Rolando Cimaz(University of Milan), Maria Cristina Maggio(University of Palermo), Giacomo Emmi(Ospedale di Cattinara), Marco Cattalini(University of Brescia), Roberta Priori(Sapienza University of Rome), Antonella Insalaco(Bambino Gesù Children's Hospital), Fabrizio De Benedetti(Bambino Gesù Children's Hospital), Raffaele Manna(Università Cattolica del Sacro Cuore), Micol Frassi(University of Brescia), Alma Nunzia Olivieri(University of Naples Federico II), Maria Alessio(University of Naples Federico II), Carla Gaggiano(Azienda Ospedaliera Universitaria Senese), Claudia Fabiani(University of Siena), Carlo Salvarani(University of Modena and Reggio Emilia), Romina Gallizzi(University of Messina), Armin Maier(Ospedale di Bolzano), Daniele Cammelli(Azienda Ospedaliero-Universitaria Careggi)
Cited by 45
Related Papers
EULAR recommendations for the management of systemic lupus erythematosus: 2023 update
|Annals of the Rheumatic Diseases|2023|913
Effect of Tocilizumab vs Standard Care on Clinical Worsening in Patients Hospitalized With COVID-19 Pneumonia
|JAMA Internal Medicine|2020|732
Treat-to-target in systemic lupus erythematosus: recommendations from an international task force
|Annals of the Rheumatic Diseases|2014|726
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616